Bristol-Myers Squibb is having a busy holiday period, signing a $4.1 billion deal to acquire cancer drug developer RayzeBio – its second multibillion-dollar M&A deal in the space of a week.

or T cell (iT) platforms, with BMS taking an option on two others in either blood cancers or solid tumours. Century will handle preclinical development, with BMS taking over when the programmes ...

4, 2025 — Research has shown that a potential ... 28, 2025 — A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse -- a mouse ...

Feb. 12, 2025 — Scientists have uncovered the equipment that enables bacteria to survive exposure to antibiotics: a shuttling mechanism that helps a complex of proteins pump out a wide spectrum ...

Cell biology is the discipline of biological sciences that studies the structure, physiology, growth, reproduction and death of cells. Research in cell biology uses microscopic and molecular tools ...

25 Years of 21st Century: Kirsty Wark and guests discuss how visual art and architecture have changed since the year 2000. Kirsty Wark & guests discuss how art and architecture have evolved over ...

Despite diverse demands, we bet that you always want to choose the most powerful solar generator, right? Some might need a powerful and ultra-lightweight model for maneuvering while others need a ...

Be a part of our ever growing community. Semicon Media is a unique collection of online media, focused purely on the Electronics Community across the globe. With a perfectly blended team of Engineers ...

There’s minimal attention being paid to cybersecurity in the design, operation and training surrounding BESS systems ...